SOPHiA GENETICS SA (SOPH) Misses Q4 EPS by 15c, Misses on Revenue; Offers FY24 Revenue Guidance

SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q4 EPS of ($0.37), $0.15 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $17 million versus the consensus estimate of $17.33 million.

GUIDANCE:

SOPHiA GENETICS SA sees FY2024 revenue of $78-81 million, versus the consensus of $82.1 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.

You May Also Be Interested In

• Lucid reports Q2 output, names new CFO and five other leaders
• Aecon wins $1.7B share of Alberta power plant contract
• Constellation Brands (STZ) Tops Q1 EPS by 18c